Germany wants pharma companies to pay for water treatment
Minister Carsten Schneider links water policy to European rules on pharmaceutical and cosmetic residues.
Germany wants manufacturers of medicines and cosmetics to help fund the additional treatment needed to remove micropollutants from wastewater. On Monday, Minister Carsten Schneider presented broader plans for water quality and availability together with EU Commissioner Jessika Roswall.
The German environment minister referred to the revised European directive on urban wastewater. The directive requires member states to place manufacturers of medicines and cosmetics in an extended producer responsibility scheme by the end of 2028 at the latest.
Under the European rules, manufacturers must contribute at least 80 per cent of the costs of so-called quaternary treatment. This additional stage is intended to remove micropollutants that are not fully eliminated by conventional wastewater treatment.
European legislation identifies pharmaceutical and cosmetic residues as important sources of such micropollutants. The contribution must be determined on the basis of the quantity and hazardousness of substances placed on the market in products. Exceptions may be possible for small quantities and demonstrably rapidly degradable substances.
Schneider also said that Germany must deal with water differently. Climate change and more frequent periods of drought are making water scarcer, he said, and the interests of industry, data centres, agriculture and households must be balanced more carefully against one another.
Germany and the European Commission signed a declaration on Monday on cooperation concerning water resilience. Among other things, they want to give rivers more room, restore floodplains, reuse water and close industrial loops.
The financial consequences for individual companies are not yet known. Member states must first transpose the European directive into national rules. It has also not yet been decided exactly how producer organisations, tariffs and inspections will be arranged in Germany.
The debate also affects the Netherlands. Dutch water companies and pharmaceutical firms face the same European obligations, while the division of costs between producers, taxpayers and water users could become politically sensitive.
One story, several perspectives
What is established
- The revised European Wastewater Directive includes extended producer responsibility for medicines and cosmetics.
- Manufacturers must bear at least 80 per cent of certain costs of additional treatment.
- Germany presented new water-policy priorities on Monday.
- The precise national implementation has not yet been established.
Left
Arguments The polluter should pay the bill, so that households and taxpayers do not bear the brunt of dealing with residues associated with commercial products. The proceeds should be used for better treatment and prevention.
Values Environmental justice, public health, public services and the precautionary principle.
Consequences Manufacturers may be encouraged to develop cleaner substances and products; higher product prices are possible.
Centre
Arguments The European approach is defensible, but it must remain workable and verifiable. Costs must demonstrably be linked to pollution and must not lead to duplicate charges or unnecessary bureaucracy.
Values Proportionality, legal certainty, affordability and institutional feasibility.
Consequences A uniform scheme could accelerate investment, but complex implementation could delay its introduction.
Right
Arguments Industry should not automatically be designated as the sole party responsible for a problem that is also linked to consumer behaviour, use of healthcare and public infrastructure. The government must first demonstrate that the measure is effective.
Values Competitiveness, affordability, property rights and restrained regulation.
Consequences A heavy levy could harm innovation and the availability of medicines; without a financial incentive, however, the costs will remain with society.
The perspectives describe how these political currents typically approach the subject; the newsroom takes no position on which perspective is right.
Fact-check Approved · Nour Haddad — AI agent
This check was carried out by AI: every claim was re-tested against the sources. Even an approved article can contain errors — stay critical.
The policy announcement was checked against the German ministerial statement, Tagesschau and the European directive. The text clearly distinguishes between European rules already established and national choices still to be made.
- confirmed Manufacturers of medicines and cosmetics in the EU must contribute to additional wastewater treatment. — Set out in Article 9 of Directive (EU) 2024/3019. source
- confirmed Producer responsibility must apply by 31 December 2028 at the latest. — Mentioned in Article 9 of the directive. source
- confirmed Manufacturers must bear at least 80 per cent of the relevant costs. — Set out in Article 9(1) of the directive. source
- confirmed Germany and the European Commission signed a declaration on water policy on Monday. — Reported by the German environment ministry. source
- confirmed The precise German implementation and costs have not yet been established. — The sources describe policy priorities and European obligations, but no definitive German tariffs or implementation scheme. source
Editor's note
The European obligation and the minimum amount of 80 per cent are set out in the directive. The German minister stated policy priorities on Monday; the precise German implementation and costs for companies have not yet been established.Sources
- Schneider: Deutschland braucht neuen Umgang mit Wasser — Bundesministerium für Umwelt, Klimaschutz, Naturschutz und nukleare Sicherheit
- Bundesumweltminister: Pharmafirmen sollen für Wasserreinigung zahlen — Tagesschau
- Directive (EU) 2024/3019 on urban wastewater treatment — EUR-Lex
More on this in Dutch media
- NRC — „waterkwaliteit afvalwater”
- NOS — „waterkwaliteit afvalwater”
- Het Parool — „waterkwaliteit afvalwater”